BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24002594)

  • 1. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO).
    Pesatori AC; Carugno M; Consonni D; Hung RJ; Papadoupolos A; Landi MT; Brenner H; Müller H; Harris CC; Duell EJ; Andrew AS; McLaughlin JR; Schwartz AG; Wenzlaff AS; Stucker I
    Br J Cancer; 2013 Oct; 109(7):1954-64. PubMed ID: 24002594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study.
    Pesatori AC; Carugno M; Consonni D; Caporaso NE; Wacholder S; Tucker M; Landi MT
    Int J Cancer; 2013 Jun; 132(11):2630-9. PubMed ID: 23129166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis.
    Lagergren K; Lagergren J; Brusselaers N
    Int J Cancer; 2014 Nov; 135(9):2183-90. PubMed ID: 24676860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and lung cancer risk according to histologic type in Japanese men and women.
    Seki T; Nishino Y; Tanji F; Maemondo M; Takahashi S; Sato I; Kawai M; Minami Y
    Cancer Sci; 2013 Nov; 104(11):1515-22. PubMed ID: 23992614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.
    La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E
    Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies.
    Pesch B; Kendzia B; Gustavsson P; Jöckel KH; Johnen G; Pohlabeln H; Olsson A; Ahrens W; Gross IM; Brüske I; Wichmann HE; Merletti F; Richiardi L; Simonato L; Fortes C; Siemiatycki J; Parent ME; Consonni D; Landi MT; Caporaso N; Zaridze D; Cassidy A; Szeszenia-Dabrowska N; Rudnai P; Lissowska J; Stücker I; Fabianova E; Dumitru RS; Bencko V; Foretova L; Janout V; Rudin CM; Brennan P; Boffetta P; Straif K; Brüning T
    Int J Cancer; 2012 Sep; 131(5):1210-9. PubMed ID: 22052329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO).
    Kim CH; Lee YC; Hung RJ; McNallan SR; Cote ML; Lim WY; Chang SC; Kim JH; Ugolini D; Chen Y; Liloglou T; Andrew AS; Onega T; Duell EJ; Field JK; Lazarus P; Le Marchand L; Neri M; Vineis P; Kiyohara C; Hong YC; Morgenstern H; Matsuo K; Tajima K; Christiani DC; McLaughlin JR; Bencko V; Holcatova I; Boffetta P; Brennan P; Fabianova E; Foretova L; Janout V; Lissowska J; Mates D; Rudnai P; Szeszenia-Dabrowska N; Mukeria A; Zaridze D; Seow A; Schwartz AG; Yang P; Zhang ZF
    Int J Cancer; 2014 Oct; 135(8):1918-30. PubMed ID: 24615328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of menstruation and pregnancy and the risk of lung cancer in women.
    Koushik A; Parent ME; Siemiatycki J
    Int J Cancer; 2009 Nov; 125(10):2428-33. PubMed ID: 19585503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and lung cancer risk: a case-control analysis.
    Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer?
    Birch-Johansen F; Jensen A; Olesen AB; Christensen J; Tjønneland A; Kjær SK
    Cancer Causes Control; 2012 Feb; 23(2):379-88. PubMed ID: 22215431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium.
    Rosenberger A; Bickeböller H; McCormack V; Brenner DR; Duell EJ; Tjønneland A; Friis S; Muscat JE; Yang P; Wichmann HE; Heinrich J; Szeszenia-Dabrowska N; Lissowska J; Zaridze D; Rudnai P; Fabianova E; Janout V; Bencko V; Brennan P; Mates D; Schwartz AG; Cote ML; Zhang ZF; Morgenstern H; Oh SS; Field JK; Raji O; McLaughlin JR; Wiencke J; LeMarchand L; Neri M; Bonassi S; Andrew AS; Lan Q; Hu W; Orlow I; Park BJ; Boffetta P; Hung RJ
    Carcinogenesis; 2012 Mar; 33(3):587-97. PubMed ID: 22198214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of oral contraceptives use and lung cancer risk among women: an updated meta-analysis based on cohort and case-control studies.
    Wu W; Yin ZH; Guan P; Ren YW; Zhou BS
    Asian Pac J Cancer Prev; 2014; 15(3):1205-10. PubMed ID: 24606442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
    Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium.
    Zhang LR; Morgenstern H; Greenland S; Chang SC; Lazarus P; Teare MD; Woll PJ; Orlow I; Cox B; ; Brhane Y; Liu G; Hung RJ
    Int J Cancer; 2015 Feb; 136(4):894-903. PubMed ID: 24947688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study.
    Brenner DR; Fehringer G; Zhang ZF; Lee YA; Meyers T; Matsuo K; Ito H; Vineis P; Stucker I; Boffetta P; Brennan P; Christiani DC; Diao N; Hong YC; Landi MT; Morgenstern H; Schwartz AG; Rennert G; Saliba W; McLaughlin JR; Harris CC; Orlow I; Barros Dios JM; Ruano Raviña A; Siemiatycki J; Koushik A; Cote M; Lazarus P; Fernandez-Tardon G; Tardon A; Le Marchand L; Brenner H; Saum KU; Duell EJ; Andrew AS; Consonni D; Olsson A; Hung RJ; Straif K
    Cancer Epidemiol; 2019 Feb; 58():25-32. PubMed ID: 30445228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive and hormonal factors and the risk of nonsmall cell lung cancer.
    Meinhold CL; Berrington de González A; Bowman ED; Brenner AV; Jones RT; Lacey JV; Loffredo CA; Perlmutter D; Schonfeld SJ; Trivers GE; Harris CC
    Int J Cancer; 2011 Mar; 128(6):1404-13. PubMed ID: 20473922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and incidence of lung cancer: a meta-analysis.
    Yang Y; Dong J; Sun K; Zhao L; Zhao F; Wang L; Jiao Y
    Int J Cancer; 2013 Mar; 132(5):1162-9. PubMed ID: 22777722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous hormone therapy and non-melanoma skin cancer (keratinocyte carcinoma) risk in women: a systematic review and meta-analysis.
    Li L; Pei B; Feng Y
    BMC Cancer; 2023 Oct; 23(1):946. PubMed ID: 37803321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.